Shares of Corteva, Inc. (NYSE:CTVA – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty-two analysts that are covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $82.90.
A number of research firms recently issued reports on CTVA. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. BNP Paribas Exane increased their price target on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Oppenheimer set a $86.00 price target on shares of Corteva in a research note on Thursday, February 5th. Citigroup boosted their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Finally, Royal Bank Of Canada upped their price objective on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th.
Check Out Our Latest Report on Corteva
Insider Activity at Corteva
Institutional Investors Weigh In On Corteva
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Activest Wealth Management boosted its position in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC purchased a new stake in shares of Corteva in the third quarter worth $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the period. Total Investment Management Inc. purchased a new position in shares of Corteva during the 2nd quarter valued at $27,000. Finally, Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva during the 4th quarter valued at $27,000. 81.54% of the stock is owned by hedge funds and other institutional investors.
Corteva Stock Down 0.9%
Corteva stock opened at $82.00 on Friday. Corteva has a one year low of $53.40 and a one year high of $82.89. The stock has a fifty day moving average of $76.25 and a 200 day moving average of $69.68. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a market cap of $55.05 billion, a PE ratio of 51.90, a price-to-earnings-growth ratio of 2.83 and a beta of 0.72.
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same period last year, the firm posted $0.32 earnings per share. The business’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva will post 2.96 EPS for the current year.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
